ClinicalTrials.Veeva

Menu

Effects of Mulligan Mobilization With and Without Dry Needling in Runner's Knee

R

Riphah International University

Status

Completed

Conditions

Runner's Knee

Treatments

Other: Mulligan mobilization with dry needling.
Other: Mulligan mobilization without dry needling

Study type

Interventional

Funder types

Other

Identifiers

NCT06086860
REC/RCR&AHS/23/0137 Mahnoor

Details and patient eligibility

About

The aim of this study is to determine the effects of Mulligan mobilization with and without dry needling on pain, range of motion, flexibility, functional disability and muscle strength in patients with Runner's Knee.

Full description

Runner's knee or patellofemoral pain syndrome (PFPS) is a common cause of anterior knee pain in young active individuals. Patellofemoral pain (PFP), or anterior knee pain (AKP), is a common musculoskeletal disorder. It involves dysfunction in mechanical forces between the patella and the femur. The worldwide PFP prevalence has been reported as 15-45% of population. Females are at two times higher risk of PFP than males, especially young active females. The aim of this study is to determine the effects of Mulligan mobilization with and without dry needling in Runner's Knee in a randomized clinical trial.

The study will be randomized clinical trial. The study will be conducted at Johar Pain Relief Center, Lahore. The study will be completed within eight months after synopsis approval from ethical committee of Riphah College of Rehabilitation and Allied Health sciences. Sample size will be 40 (20 in each group). Non-probability convenience sampling technique will be used to recruit the Runner's Knee patients in the study and then they will be divided into two groups by simple randomization through sealed opaque envelope. Mulligan mobilization with dry needling will be given to group A. Mulligan mobilization without dry needling will be given to group B. Outcome measures will be pain, knee range of motion, flexibility, functional disability and muscle strength measured through Numeric pain rating scale (NPRS), goniometer, Kujala Patellofemoral Scale and Modified Sphygmomanometer Test (MST) respectively. Data will be analyzed by SPSS version 25.

Enrollment

40 patients

Sex

All

Ages

20 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients of both genders.
  • Individuals aged 20-45 years with a clinical diagnosis of Runner's Knee.
  • Participants experiencing retropatellar or anterior knee pain during at least two activities such as ascending and descending stairs, squatting, kneeling, or prolonged sitting, jumping or running.
  • Pain scoring rate on numeric pain rating scale (NPRS) ≥ 3 during at least two activities.
  • Duration lasting longer than two months.

Exclusion criteria

  • Patients with a history of meniscus tears, bursitis, patellar tendon injury, ligamentous injury, joint degeneration, patellofemoral dislocation and / or recurrent subluxation.
  • Participants with a history of arthritis.
  • Individuals with a history of lower extremity surgery.
  • Patients having knee pain referred from hip, lumbar spine and ankle joints.
  • Any systemic disease and/or connective tissue disorders, or lumbosacral nerve root compression.
  • Patients taking any pain medications.
  • Individuals who previously received acupuncture therapy, injection, or dry needling technique for knee extensor muscle in last six months.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Mulligan mobilization with dry needling.
Experimental group
Description:
Participants in this group will receive Mulligan mobilization with dry needling.
Treatment:
Other: Mulligan mobilization with dry needling.
Mulligan mobilization without dry needling.
Active Comparator group
Description:
Participants in this group will receive Mulligan mobilization without dry needling.
Treatment:
Other: Mulligan mobilization without dry needling

Trial contacts and locations

1

Loading...

Central trial contact

Imran Amjad, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems